| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |